WASHINGTON, July 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that at a general meeting of shareholders of Renergen Limited ("Renergen") held on July 10, 2025, Renergen shareholders voted overwhelmingly in favor of the acquisition of Renergen by ASP Isotopes through a scheme of arrangement (the ...

WASHINGTON, June 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), today announced the pricing of an underwritten registered direct offering of 7,518,797 shares of its common stock at a price of $6.65 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50.0 million. The offering is expected to close on or abo ...

Core Viewpoint - The proposed acquisition of Renergen by ASP Isotopes aims to create a global leader in the production of critical materials, particularly in electronic gases and isotopes, with significant synergies expected from 2026 [1][5][9]. Transaction Overview - The transaction is anticipated to be highly accretive to ASP Isotopes' earnings per share (EPS) by 2026, with a goal of generating over $300 million in EBITDA by 2030 [2][9]. - The acquisition has received support from over 35% of Renergen shareholders and is expected to close in Q3 2025 [3][18]. - The deal involves Renergen shareholders receiving 0.09196 new ASP Isotopes shares for each share held, with a total share consideration not exceeding 14,270,000 shares [16]. Financial Aspects - Renergen's Virginia Gas project, which has helium concentrations over 10 times the global average, has received $40 million in funding and is expected to benefit from an additional $750 million in debt funding [6]. - The combined group is projected to lower isotope enrichment costs by 96% compared to current cash costs [8]. - ASP Isotopes plans to secure $30 million in debt financing to support the acquisition and operations [21]. Strategic Importance - The combination is expected to create a vertically and horizontally integrated supply chain, enhancing the ability to service key markets such as medical, semiconductor, and energy industries [10][11]. - The acquisition aligns with U.S. interests in securing supplies of critical materials essential for future technologies like quantum computing [13][22]. Management and Operations - Renergen will operate as a subsidiary of ASP Isotopes, maintaining its current management team while receiving operational support from ASP Isotopes [17]. - The headquarters of the combined group will relocate to Austin, Texas, facilitating closer proximity to customers [12]. Market Position - The combined entity is positioned to capitalize on the growing demand for isotopes and helium, which are increasingly recognized as critical materials by Western governments [22][24]. - The deal represents a significant opportunity for ASP Isotopes to enhance its market presence and operational capabilities in the isotope and helium sectors [14][22].

Company Overview - ASP Isotopes Inc. is a development stage advanced materials company focused on producing isotopes for various industries using proprietary technology known as the Aerodynamic Separation Process (ASP technology) [2] - The company's initial focus is on highly enriched isotopes for healthcare and technology sectors, with plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [2] Industry Demand - There is an increasing demand for specific isotopes such as Silicon-28 for quantum computing, Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for emerging healthcare applications [3] - Additional isotopes like Chlorine-37, Lithium-6, Lithium-7, and Uranium-235 are sought after for green energy applications [3] - The ASP Technology is particularly suitable for enriching both low and heavy atomic mass molecules, indicating its versatility in the isotope production market [3] Upcoming Events - The company will host an investor webcast on May 20, 2025, at 8:00 a.m. EST, which will be accessible online and archived for at least 90 days [1]

Core Insights - ASP Isotopes Inc. is undergoing a strategic separation of its Nuclear Fuels Business and Specialist Isotope Products into two independent companies, with plans to complete this by the second half of 2025 [2][5][8] - Mr. Sipho Maseko has joined the board of directors of ASP Isotopes, bringing extensive experience from his previous roles in telecommunications and industrial sectors [1][3][4] - Dr. Hendrik Strydom has transitioned from the board of directors of ASP Isotopes to the board of managers of Quantum Leap Energy LLC, focusing on advanced nuclear fuel production [2][6][7] Company Developments - The separation will involve a spin-out of Quantum Leap Energy LLC, which aims to develop advanced nuclear fuels such as HALEU and Lithium-6, and will become a separate public company [5][8] - The board of directors is evaluating the optimal composition for the board of managers of Quantum Leap Energy LLC, with Dr. Strydom now part of this team [6][7] - The company is committed to maximizing shareholder value during the separation process and will consider various options to achieve this [8] Leadership and Expertise - Mr. Maseko has a strong background in various industries, including telecommunications and energy, and has been instrumental in advancing ASP Isotopes' business in South Africa [3][4] - Dr. Strydom has a 40-year career in isotope enrichment and has previously worked on nuclear fuel programs, enhancing the company's technical capabilities [6][7] Market Focus - ASP Isotopes is dedicated to producing isotopes for multiple industries, including healthcare and technology, and is developing proprietary technologies for isotope enrichment [10][11] - There is a growing demand for isotopes in emerging applications, particularly in quantum computing and green energy, which the company aims to address [11]

WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), announced that it will release its fourth quarter and fiscal year 2024 financial results after the close of financial markets today, March 31, 2025, with a webinar to follow tomorrow, Tuesday, April 1, 2025 at 10:00 am ET, 3:00 pm UK time, 4:00 pm South African time. Participating in the webinar will be Paul Mann, Chairman and CEO of the Company. Mr. Mann will give a review of the Company's finan ...